Differential regulation of Tregs and Th17/Th1 cells by a sirolimus-based regimen might be dependent on STAT-signaling in renal transplant recipients

International Immunopharmacology

Volumn 28, Issue 1, 2015, Pages 435-443

  Li, Yi ^a   Shi, Yunying ^a   Liao, Yun ^a   Yan, Lin ^a   Zhang, Qi ^a   Wang, Lanlan ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Calcineurin inhibitors; Regulatory T cells; Renal transplantation; Sirolimus; Stat proteins; Th17 cells

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 6; RAPAMYCIN; STAT PROTEIN; STAT3 PROTEIN; STAT5 PROTEIN; TACROLIMUS; CYTOKINE; IMMUNOSUPPRESSIVE AGENT;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CHOLESTEROL BLOOD LEVEL; CHRONIC ALLOGRAFT NEPHROPATHY; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DOWN REGULATION; EFFECTOR CELL; FEMALE; GRAFT RECIPIENT; HUMAN; HYPERLIPIDEMIA; IMMUNOREGULATION; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN INDUCTION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; SYSTOLIC BLOOD PRESSURE; TH1 CELL; TH17 CELL; BLOOD; CONTROLLED CLINICAL TRIAL; IMMUNOLOGY; MIDDLE AGED;

ADULT; CYTOKINES; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; SIROLIMUS; T-LYMPHOCYTES, REGULATORY; TACROLIMUS; TH1 CELLS; TH17 CELLS;

EID: 84937422644     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2015.07.006     Document Type: Article

References (22)

1. J. Gralla, and A.C. Wiseman Tacrolimus/sirolimus versus tacrolimus/mycophenolate in kidney transplantation: improved 3-year graft and patient survival in recent era Transplantation 87 2009 1712 1719
2. S.M. Flechner, D. Goldfarb, K. Solez, C.S. Modlin, B. Mastroianni, K. Savas, and et al. Kidney transplantation with sirolimus and mycophenolate mofetil-based immunosuppression: 5-year results of a randomized prospective trial compared to calcineurin inhibitor drugs Transplantation 83 2007 883 892
3. T.R. Srinivas, J.D. Schold, G. Guerra, A. Eagan, C.M. Bucci, and H.U. Meier-Kriesche Mycophenolate mofetil/sirolimus compared to other common immunosuppressive regimens in kidney transplantation Am. J. Transplant. 7 2007 586 594
4. A. Laurence, C.M. Tato, T.S. Davidson, Y. Kanno, Z. Chen, Z. Yao, and et al. Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation Immunity 26 2007 371 381
5. Y. Li, Y. Shi, Z. Huang, Y. Bai, Q. Niu, B. Cai, and et al. CNI induced Th17/Treg imbalance and susceptibility to renal dysfunction in renal transplantation Int. Immunopharmacol. 11 2011 2033 2038
6. H. Sugiyama, Y. Maeda, H. Nishimori, Y. Yamasuji, K.I. Matsuoka, N. Fujii, and et al. Mammalian target of rapamycin inhibitors permit regulatory T cell reconstitution and inhibit experimental chronic graft-versus-host disease Biol. Blood Marrow Transplant. 20 2013 183 191
7. M. Battaglia, A. Stabilini, B. Migliavacca, J. Horejs-Hoeck, T. Kaupper, and M.G. Roncarolo Rapamycin promotes expansion of functional CD4 + CD25 + FOXP3 + regulatory T cells of both healthy subjects and type 1 diabetic patients J. Immunol. 177 2006 8338 8347
8. M. Battaglia, A. Stabilini, and M.G. Roncarolo Rapamycin selectively expands CD4 + CD25 + FoxP3 + regulatory T cells Blood 105 2005 4743 4748
9. L. Strauss, T.L. Whiteside, A. Knights, C. Bergmann, A. Knuth, and A. Zippelius Selective survival of naturally occurring human CD4 + CD25 + Foxp3 + regulatory T cells cultured with rapamycin J. Immunol. 178 2007 320 329
10. G.Y. Wang, Q. Zhang, Y. Yang, W.J. Chen, W. Liu, N. Jiang, and et al. Rapamycin combined with allogenic immature dendritic cells selectively expands CD4 + CD25 + Foxp3 + regulatory T cells in rats Hepatobiliary Pancreat. Dis. Int. 11 2012 203 208
11. G.M. Delgoffe, T.P. Kole, Y. Zheng, P.E. Zarek, K.L. Matthews, B. Xiao, and et al. The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment Immunity 30 2009 832 844
12. G.M. Delgoffe, K.N. Pollizzi, A.T. Waickman, E. Heikamp, D.J. Meyers, M.R. Horton, and et al. The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2 Nat. Immunol. 12 2011 295 303
13. J. Ge, K. Wang, Q.H. Meng, Z.X. Qi, F.L. Meng, and Y.C. Fan Implication of Th17 and Th1 cells in patients with chronic active hepatitis B J. Clin. Immunol. 30 2010 60 67
14. W. Wu, J. Li, F. Chen, H. Zhu, G. Peng, and Z. Chen Circulating Th17 cells frequency is associated with the disease progression in HBV infected patients J. Gastroenterol. Hepatol. 25 2010 750 757
15. S.N. Sehgal Rapamune (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression Clin. Biochem. 31 1998 335 340
16. J. Kang, S.J. Huddleston, J.M. Fraser, and A. Khoruts De novo induction of antigen-specific CD4 + CD25 + Foxp3 + regulatory T cells in vivo following systemic antigen administration accompanied by blockade of mTOR J. Leukoc. Biol. 83 2008 1230 1239
17. H. Kopf, G.M. de la Rosa, O.M. Howard, and X. Chen Rapamycin inhibits differentiation of Th17 cells and promotes generation of FoxP3 + T regulatory cells Int. Immunopharmacol. 7 2007 1819 1824
18. D. Valmori, V. Tosello, N.E. Souleimanian, E. Godefroy, L. Scotto, Y. Wang, and et al. Rapamycin-mediated enrichment of T cells with regulatory activity in stimulated CD4 + T cell cultures is not due to the selective expansion of naturally occurring regulatory T cells but to the induction of regulatory functions in conventional CD4 + T cells J. Immunol. 177 2006 944 949
19. D. Unutmaz, E. Yurchenko, M.T. Shio, T.C. Huang, Martins M. Da Silva, M. Szyf, and et al. Inflammation-driven reprogramming of CD4 + Foxp3 + regulatory T cells into pathogenic Th1/Th17 T effectors is abrogated by mTOR inhibition in vivo PLoS One 7 2012 e35572
20. H. Yin, X. Li, B. Zhang, T. Liu, B. Yuan, Q. Ni, and et al. Sirolimus ameliorates inflammatory responses by switching the regulatory T/T helper type 17 profile in murine colitis Immunology 139 2013 494 502
21. T.Y. Wuest, J. Willette-Brown, S.K. Durum, and A.A. Hurwitz The influence of IL-2 family cytokines on activation and function of naturally occurring regulatory T cells J. Leukoc. Biol. 84 2008 973 980
22. X.-P. Yang, K. Ghoreschi, S.M. Steward-Tharp, J. Rodriguez-Canales, J. Zhu, J.R. Grainger, and et al. Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5 Nat. Immunol. 12 2011 247 254